Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00710580
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 350
Large-scale testing (Phase 3)Study completedNCT04761627
What this trial is testing

Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 494
Testing effectiveness (Phase 2)Study completedNCT03850483
What this trial is testing

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Who this might be right for
Psoriasis
Pfizer 344
Post-approval studies (Phase 4)Study completedNCT00940862
What this trial is testing

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisVascular InflammationCoronary Atherosclerosis
Innovaderm Research Inc. 30
Large-scale testing (Phase 3)Study completedNCT00338754
What this trial is testing

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 160
Testing effectiveness (Phase 2)Study completedNCT00606450
What this trial is testing

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 260
Testing effectiveness (Phase 2)Study completedNCT06278350
What this trial is testing

Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 161
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Not applicableStudy completedNCT00096928
What this trial is testing

Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Who this might be right for
Psoriasis
Genentech, Inc. 1,846
Large-scale testing (Phase 3)Study completedNCT06122649
What this trial is testing

Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Who this might be right for
Plaque Psoriasis
Amgen 203
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Testing effectiveness (Phase 2)Study completedNCT01043393
What this trial is testing

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT06844799
What this trial is testing

HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Hansoh BioMedical R&D Company 720
Not applicableStudy completedNCT00705900
What this trial is testing

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
NeoStrata Company, Inc. 60
Large-scale testing (Phase 3)Ended earlyNCT00090129
What this trial is testing

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Arthritis, Psoriatic
EMD Serono 854
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150988
What this trial is testing

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 150
Post-approval studies (Phase 4)Looking for participantsNCT04347473
What this trial is testing

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 25
Testing effectiveness (Phase 2)Study completedNCT01225731
What this trial is testing

Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 355
Large-scale testing (Phase 3)Study completedNCT03535194
What this trial is testing

Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,484
Large-scale testing (Phase 3)Not Yet RecruitingNCT06943950
What this trial is testing

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
CSPC Ouyi Pharmaceutical Co., Ltd. 500
Next Page